{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:51:16Z","timestamp":1791265876874,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T00:00:00Z","timestamp":1572220800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T00:00:00Z","timestamp":1572220800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Von Hippel-Lindau (VHL) disease is a multi-systemic hereditary disease associated with several benign and malignant tumor entities, including clear cell renal cell carcinoma (ccRCC). Since ccRCCs grow slowly, nephron sparing surgery is typically performed at a tumor diameter of 3\u20134\u2009cm before the tumor metastasizes. However, in the case of recurrent disease, repeated surgical intervention can impair renal function. Therefore, it is crucial to optimize the timing for surgical interventions through a better understanding of the growth kinetics of ccRCCs in VHL. We investigated tumor growth kinetics and modern volumetric assessment to guide future therapeutic decisions.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The prevalence of ccRCC was 28% in a cohort of 510 VHL patients. Of 144 patients with ccRCC, 41 were followed with serial imaging which identified 102 renal tumors, which exhibited heterogeneous growth kinetics. ccRCCs grew at an average absolute growth rate of 0.287\u2009cm\/year, an average relative growth rate [<jats:italic>(lnV<\/jats:italic><jats:sub><jats:italic>1<\/jats:italic><\/jats:sub><jats:italic>-lnV<\/jats:italic><jats:sub><jats:italic>0<\/jats:italic><\/jats:sub><jats:italic>)\/(t<\/jats:italic><jats:sub><jats:italic>1<\/jats:italic><\/jats:sub><jats:italic>-t<\/jats:italic><jats:sub><jats:italic>0<\/jats:italic><\/jats:sub><jats:italic>)<\/jats:italic>] of 0.42% and an average volume doubling time of 27.15\u2009months. Women had a faster relative growth rate than men. Age and specific mutations did not influence tumor growth. Because of the tumor heterogeneity, we developed an additional cut-off volume of 40\u2009cm<jats:sup>3<\/jats:sup> for surgical intervention.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Tumor heterogeneity and differences in growth kinetics is suggestive of a state of transient tumor dormancy in ccRCCs of VHL patients. The relative growth rate has not been previously described in other studies. Volumetric assessment as an additional parameter for surgical intervention could be a useful clinical tool and needs further investigation.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-019-1206-2","type":"journal-article","created":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T15:05:26Z","timestamp":1572275126000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Growth characteristics and therapeutic decision markers in von Hippel-Lindau disease patients with renal cell carcinoma"],"prefix":"10.1186","volume":"14","author":[{"given":"Patrick","family":"Schuhmacher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peggy","family":"Sekula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cordula Annette","family":"Jilg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Leiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut P.","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Schultze-Seemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Walz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7574-4085","authenticated-orcid":false,"given":"Stefan","family":"Zschiedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,28]]},"reference":[{"issue":"7","key":"1206_CR1","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1136\/jmg.28.7.443","volume":"28","author":"ER Maher","year":"1991","unstructured":"Maher ER, Iselius L, Yates JR, Littler M, Benjamin C, Harris R, et al. Von Hippel-Lindau disease: a genetic study. J Med Genet. 1991;28(7):443\u20137.","journal-title":"J Med Genet"},{"issue":"8749","key":"1206_CR2","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/0140-6736(91)91705-Y","volume":"337","author":"HP Neumann","year":"1991","unstructured":"Neumann HP, Wiestler OD. Clustering of features of von Hippel-Lindau syndrome: evidence for a complex genetic locus. Lancet (London, England). 1991;337(8749):1052\u20134.","journal-title":"Lancet (London, England)"},{"issue":"2","key":"1206_CR3","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1136\/jmg.33.2.120","volume":"33","author":"IR Maddock","year":"1996","unstructured":"Maddock IR, Moran A, Maher ER, Teare MD, Norman A, Payne SJ, et al. A genetic register for von Hippel-Lindau disease. J Med Genet. 1996;33(2):120\u20137.","journal-title":"J Med Genet"},{"issue":"5","key":"1206_CR4","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1016\/S0022-5347(05)68930-6","volume":"161","author":"MM Walther","year":"1999","unstructured":"Walther MM, Choyke PL, Glenn G, Lyne JC, Rayford W, Venzon D, et al. Renal cancer in families with hereditary renal cancer: prospective analysis of a tumor size threshold for renal parenchymal sparing surgery. J Urol. 1999;161(5):1475\u20139.","journal-title":"J Urol"},{"issue":"1","key":"1206_CR5","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1046\/j.1365-2362.1999.00402.x","volume":"29","author":"FJ Hes","year":"1999","unstructured":"Hes FJ, Slootweg PJ, van Vroonhoven TJ, Hene RJ, Feldberg MA, Zewald RA, et al. Management of renal cell carcinoma in von Hippel-Lindau disease. Eur J Clin Investig. 1999;29(1):68\u201375.","journal-title":"Eur J Clin Investig"},{"issue":"3","key":"1206_CR6","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.urology.2007.04.040","volume":"70","author":"G Ploussard","year":"2007","unstructured":"Ploussard G, Droupy S, Ferlicot S, Ples R, Rocher L, Richard S, et al. Local recurrence after nephron-sparing surgery in von Hippel-Lindau disease. Urology. 2007;70(3):435\u20139.","journal-title":"Urology."},{"issue":"1","key":"1206_CR7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1159\/000333348","volume":"88","author":"CA Jilg","year":"2012","unstructured":"Jilg CA, Neumann HP, Glasker S, Schafer O, Ardelt PU, Schwardt M, et al. Growth kinetics in von Hippel-Lindau-associated renal cell carcinoma. Urol Int. 2012;88(1):71\u20138.","journal-title":"Urol Int"},{"key":"1206_CR8","unstructured":"VHL Alliance. 2018 [Available from: \n                    http:\/\/www.vhl.org\n                    \n                  ]."},{"key":"1206_CR9","unstructured":"Verein_VHL-betroffener_Familien_e.V. 2018 [Available from: \n                    http:\/\/www.hippel-lindau.de\/\n                    \n                  ]."},{"issue":"12","key":"1206_CR10","first-page":"B4763","volume":"60","author":"ML Binderup","year":"2013","unstructured":"Binderup ML, Bisgaard ML, Harbud V, Moller HU, Gimsing S, Friis-Hansen L, et al. Von Hippel-Lindau disease (vHL). National clinical guideline for diagnosis and surveillance in Denmark. 3rd edition. Dan Med J. 2013;60(12):B4763.","journal-title":"Dan Med J"},{"issue":"3","key":"1206_CR11","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s10689-012-9525-7","volume":"11","author":"CA Jilg","year":"2012","unstructured":"Jilg CA, Neumann HP, Glasker S, Schafer O, Leiber C, Ardelt PU, et al. Nephron sparing surgery in von Hippel-Lindau associated renal cell carcinoma; clinicopathological long-term follow-up. Familial Cancer. 2012;11(3):387\u201394.","journal-title":"Familial Cancer"},{"issue":"1","key":"1206_CR12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/01.ju.0000132127.79974.3f","volume":"172","author":"BG Duffey","year":"2004","unstructured":"Duffey BG, Choyke PL, Glenn G, Grubb RL, Venzon D, Linehan WM, et al. The relationship between renal tumor size and metastases in patients with von Hippel-Lindau disease. J Urol. 2004;172(1):63\u20135.","journal-title":"J Urol"},{"issue":"2","key":"1206_CR13","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/humu.20385","volume":"28","author":"KR Ong","year":"2007","unstructured":"Ong KR, Woodward ER, Killick P, Lim C, Macdonald F, Maher ER. Genotype-phenotype correlations in von Hippel-Lindau disease. Hum Mutat. 2007;28(2):143\u20139.","journal-title":"Hum Mutat"},{"issue":"283","key":"1206_CR14","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1093\/qjmed\/77.2.1151","volume":"77","author":"ER Maher","year":"1990","unstructured":"Maher ER, Yates JR, Harries R, Benjamin C, Harris R, Moore AT, et al. Clinical features and natural history of von Hippel-Lindau disease. Q J Med. 1990;77(283):1151\u201363.","journal-title":"Q J Med"},{"issue":"12","key":"1206_CR15","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1097\/00007890-199712270-00017","volume":"64","author":"DA Goldfarb","year":"1997","unstructured":"Goldfarb DA, Neumann HP, Penn I, Novick AC. Results of renal transplantation in patients with renal cell carcinoma and von Hippel-Lindau disease. Transplantation. 1997;64(12):1726\u20139.","journal-title":"Transplantation."},{"issue":"6","key":"1206_CR16","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.3346\/jkms.2009.24.6.1145","volume":"24","author":"WT Kim","year":"2009","unstructured":"Kim WT, Ham WS, Ju HJ, Lee JS, Lee JS, Choi YD. Clinical characteristics of renal cell carcinoma in Korean patients with von Hippel-Lindau disease compared to sporadic bilateral or multifocal renal cell carcinoma. J Korean Med Sci. 2009;24(6):1145\u20139.","journal-title":"J Korean Med Sci"},{"issue":"7","key":"1206_CR17","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s00432-014-1654-y","volume":"140","author":"T Kwon","year":"2014","unstructured":"Kwon T, Jeong IG, Pak S, You D, Song C, Hong JH, et al. Renal tumor size is an independent prognostic factor for overall survival in von Hippel-Lindau disease. J Cancer Res Clin Oncol. 2014;140(7):1171\u20137.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"6","key":"1206_CR18","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1016\/S0022-5347(01)67318-X","volume":"153","author":"F Steinbach","year":"1995","unstructured":"Steinbach F, Novick AC, Zincke H, Miller DP, Williams RD, Lund G, et al. Treatment of renal c cell carcinoma in von Hippel-Lindau disease: a multicenter study. J Urol. 1995;153(6):1812\u20136.","journal-title":"J Urol"},{"issue":"2","key":"1206_CR19","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S0022-5347(05)00148-5","volume":"175","author":"SN Chawla","year":"2006","unstructured":"Chawla SN, Crispen PL, Hanlon AL, Greenberg RE, Chen DY, Uzzo RG. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol. 2006;175(2):425\u201331.","journal-title":"J Urol"},{"issue":"6","key":"1206_CR20","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.2214\/ajr.159.6.1442389","volume":"159","author":"PL Choyke","year":"1992","unstructured":"Choyke PL, Glenn GM, Walther MM, Zbar B, Weiss GH, Alexander RB, et al. The natural history of renal lesions in von Hippel-Lindau disease: a serial CT study in 28 patients. AJR Am J Roentgenol. 1992;159(6):1229\u201334.","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"1206_CR21","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/S0022-5347(01)62509-6","volume":"160","author":"HP Neumann","year":"1998","unstructured":"Neumann HP, Bender BU, Berger DP, Laubenberger J, Schultze-Seemann W, Wetterauer U, et al. Prevalence, morphology and biology of renal cell carcinoma in von Hippel-Lindau disease compared to sporadic renal cell carcinoma. J Urol. 1998;160(4):1248\u201354.","journal-title":"J Urol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1206-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-019-1206-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1206-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T00:32:32Z","timestamp":1603758752000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-019-1206-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,28]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1206"],"URL":"https:\/\/doi.org\/10.1186\/s13023-019-1206-2","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,28]]},"assertion":[{"value":"12 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All patients gave written informed consent with was approved by the local ethics committee of the University of Freiburg (EK 391\/16).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"235"}}